Problematic severe asthma: a proposed approach to identifying children who are severely resistant to therapy

Jon R Konradsen1, Björn Nordlund, Marika Lidegran

  • 1Astrid Lindgren Children's Hospital, Karolinska University Hospital, Stockholm, Sweden.

Insights

Problematic severe asthma (PA) in children is often difficult to treat. This study identified key characteristics of children with PA, distinguishing those with therapy-resistant asthma from those with treatable aggravating factors.

Area of Science:

  • Pediatric Pulmonology
  • Allergy and Immunology
  • Respiratory Medicine

Background:

  • Problematic severe asthma (PA) in children presents challenges in management, stemming from either aggravating factors or resistance to therapy.
  • Asthma control guidelines (GINA) define PA as inadequate symptom control despite high-level treatment (Level 4).

Purpose of the Study:

  • To characterize features of school-aged children with PA.
  • To differentiate children with PA from those with controlled persistent asthma (CA).
  • To identify children with therapy-resistant asthma within the PA cohort.

Main Methods:

  • Cross-sectional, multicenter study comparing children with PA and CA.
  • Utilized questionnaires, spirometry, methacholine challenge, fractional exhaled nitric oxide (FeNO) measurements, biomarker analysis, and CT scans (PA group).

Main Results:

  • 61% of PA children had therapy-resistant asthma; others had treatable aggravating factors.
  • PA children more frequently had parental asthma history, lower socioeconomic status, reduced physical activity, and rhinoconjunctivitis comorbidity.
  • PA group showed lower FEV1 and increased bronchial hyper-responsiveness, with no significant differences in atopy or FeNO.

Conclusions:

  • A detailed clinical characterization protocol can identify distinguishing features of children with PA.
  • This approach aids in identifying children with therapy-resistant asthma.
  • Understanding these features can guide management strategies for pediatric severe asthma.

Related Concept Videos

Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Asthma-IV: Nursing Management01:30

Asthma-IV: Nursing Management

The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include: